Relationship Between Serum Xanthine Oxidase Levels and Seborrheic Keratosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-10-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study aims to examine the relationship between serum xanthine oxidase (XO) levels and seborrheic keratosis (SK), a common benign skin tumor, especially in middle-aged and older adults. The pathogenesis of SK remains unclear, but oxidative stress is believed to play a role. XO is an enzyme that contributes to the production of reactive oxygen species (ROS), which can cause oxidative damage in the skin.

A total of 80 participants will be included in the study, consisting of 40 patients diagnosed with SK and 40 healthy individuals as controls. Each participant will undergo clinical and dermoscopic examination, followed by blood sampling to measure serum XO levels using ELISA. The study will be conducted at the Dermatology and Venereology Clinic of Prof. dr. Chairuddin Panusunan Lubis Universitas Sumatera Utara Hospital from October 2023 to June 2024.

This study has been reviewed and approved by the Ethics Committee of the Faculty of Medicine, Universitas Sumatera Utara.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients

NCT00555633

Skin Cancer Xeroderma Pigmentosum Basal Cell Nevus Syndrome

COMPLETED

LOXL1 Polymorphism in Pseudoexfoliation Syndrome

NCT01515735

Pseudoexfoliation Syndrome

UNKNOWN

The Efficacy and Safety of Secukinumab in Patients With Ichthyoses

NCT03041038

Ichthyosis Autosomal Recessive Congenital Ichthyosis Lamellar Ichthyosis +3 more

COMPLETED PHASE2

Study of Scaling Disorders and Other Inherited Skin Diseases

NCT00001292

Genetic Skin Disease Keratosis Follicularis Lamellar Ichthyosis

COMPLETED

A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma

NCT01881529

Limited Scleroderma Diffuse Scleroderma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Seborrheic keratosis (SK) is one of the most common benign skin tumors observed in dermatology practice. Although SK is not malignant, its appearance can be concerning to patients, particularly when lesions are numerous or located on visible areas such as the face. The exact cause of SK is unknown, but multiple factors such as age, genetics, ultraviolet (UV) exposure, and oxidative stress have been implicated.

This observational study is designed to investigate the potential association between serum xanthine oxidase (XO) levels and the presence of SK. XO is a pro-oxidant enzyme involved in purine metabolism that generates reactive oxygen species (ROS), including superoxide and hydrogen peroxide. These ROS may play a role in oxidative stress, which is thought to contribute to various skin aging processes and possibly to benign epidermal proliferative conditions like SK.

A total of 80 participants are included in the study: 40 patients diagnosed with SK and 40 healthy controls without SK. Participants are between 18 and 50 years old and recruited from the dermatology outpatient clinic. All subjects undergo clinical and dermoscopic examination for confirmation of diagnosis. Blood samples are collected from all participants, and serum XO levels are measured using a validated enzyme-linked immunosorbent assay (ELISA) technique.

Strict inclusion and exclusion criteria are applied to minimize confounding variables, such as the presence of other dermatologic conditions, systemic illnesses, or recent antioxidant treatment. This protocol is aimed at providing foundational data to explore the biochemical basis of SK and the potential involvement of oxidative mechanisms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Seborrheic Keratosis (SK) Oxidative Stress Skin Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Seborrheic Keratosis Group

This group includes 40 participants diagnosed with seborrheic keratosis through clinical and dermoscopic examination. Venous blood was collected to measure serum xanthine oxidase (XO) levels using ELISA. Participants were between 18 and 50 years old and had no underlying systemic diseases. This group represents the case population in this observational case-control study.

Serum Xanthine Oxidase Level Assessment

Intervention Type OTHER

Blood samples were collected from each participant and serum was separated by centrifugation. Serum xanthine oxidase (XO) levels were measured using a Human XO ELISA Kit (Cat No. E3495Hu) according to the manufacturer's instructions. This intervention involved no therapeutic intent and was performed for observational biomarker analysis only.

Control Group

This group includes 40 healthy participants without seborrheic keratosis or other hyperpigmented skin lesions. They were age- and sex-matched to the case group. Blood samples were collected to determine serum XO levels using the same ELISA protocol. These individuals served as the control group for comparison of XO levels.

Serum Xanthine Oxidase Level Assessment

Intervention Type OTHER

Blood samples were collected from each participant and serum was separated by centrifugation. Serum xanthine oxidase (XO) levels were measured using a Human XO ELISA Kit (Cat No. E3495Hu) according to the manufacturer's instructions. This intervention involved no therapeutic intent and was performed for observational biomarker analysis only.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Serum Xanthine Oxidase Level Assessment

Blood samples were collected from each participant and serum was separated by centrifugation. Serum xanthine oxidase (XO) levels were measured using a Human XO ELISA Kit (Cat No. E3495Hu) according to the manufacturer's instructions. This intervention involved no therapeutic intent and was performed for observational biomarker analysis only.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 to 50 years
* Willing to participate and sign informed consent
* Able to undergo dermatologic and dermoscopic examination
* For case group: diagnosed with seborrheic keratosis
* For control group: no clinical or dermoscopic evidence of seborrheic keratosis

Exclusion Criteria

* History or presence of other hyperpigmentation skin lesions (e.g., lentigo solaris)
* Diagnosed with systemic diseases such as diabetes mellitus, cardiovascular disease, hepatitis, HIV/AIDS, gout, or renal impairment
* Taking medications that affect oxidative stress biomarkers
* Pregnant or breastfeeding women

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes